NCT01431404View on ClinicalTrials.gov

Safety and Pharmacokinetic Characteristics of HD203 Liq. in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

June 30, 2013

Conditions

Healthy

Interventions

BIOLOGICAL

Etanercept (Enbrel)

prefilled syringe, SC

BIOLOGICAL

HD203

HD203, prefilled syringe, SC injection

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

Hanwha Chemical

All Listed Sponsors

lead

Hanwha Chemical

INDUSTRY